Structure-activity relationship in a series of new 1-(2-pyrimidinyl)piperazine derivatives with hypnotic activity. 1996

Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
Pharmaceutical Research Institute, Warszawa, Poland.

Preparation, biological properties and QSAR of new derivatives of 1-[4-(2-pyrimidinyl)-1-piperazinyl]-1, 3-butandione (11-13, and 15-18) and 3-[4-(2-pirimidinyl)-1-piperazinyl]-3-oxopropanoate (20-22) exhibiting hypnotic activity in mice are reported. The best therapeutic indices (TI = LD50/ED50) 4.7 and 9.4 for po and ip administration, respectively, were found for 1-[4-(2-pyrimidinyl)-1-piperazinyl]-2-n-pentyl-1,3-butandione (15). QSAR studies showed that the biological activity grows initially with an increase in lipophilicity to drop dramatically for log P > 2.5.

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006591 Hexobarbital A barbiturate that is effective as a hypnotic and sedative. Evipan,Hexenal,Hexobarbitone,Sodium Hexobarbital,Hexobarbital, Sodium
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
January 2001, Acta poloniae pharmaceutica,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
January 1993, Eksperimental'naia i klinicheskaia farmakologiia,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
January 1992, Eksperimental'naia i klinicheskaia farmakologiia,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
January 1990, Brain research bulletin,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
May 2002, The Journal of pharmacy and pharmacology,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
January 1989, Farmakologiia i toksikologiia,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
July 1971, Arzneimittel-Forschung,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
March 2015, European journal of medicinal chemistry,
Z Chilmonczyk, and M Bogdal, and M Mazgajska, and J Cybulski, and U Lewandowska
January 1992, Eksperimental'naia i klinicheskaia farmakologiia,
Copied contents to your clipboard!